Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea (NCT07729540) | Clinical Trial Compass
CompletedNot Applicable
Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea
Poland60 participantsStarted 2025-09-29
Plain-language summary
This study compares three approaches to treating persistent facial redness in adults with erythematotelangiectatic rosacea: intense pulsed light (IPL) treatment alone, a professional anti-redness dermocosmetic skincare regimen alone, and the combination of both. The main question the study aims to answer is which of these three strategies is more effective at reducing facial redness, using both clinician grading and objective skin-imaging tools that measure redness and skin texture before and after treatment.
Who can participate
Age range
20 Years – 57 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients with a dermatologist-confirmed diagnosis of erythematotelangiectatic rosacea
Exclusion Criteria:
* Age under 18 years
* Pregnancy or breastfeeding
* Predisposition to keloid or hypertrophic scarring
* Use of systemic or topical retinoids, antibiotics, or hormonal therapy within the washout period specified for each agent
* Chemical peeling within one month
* Laser treatment or phototherapy within three months
* Photosensitizing medications or herbal preparations
* Inflammatory dermatoses other than rosacea
* Autoimmune disease
* Active skin infection in the treatment area
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Antera 3D Erythema Index (Mean, Minimum, and Maximum)
Timeframe: Baseline, 2 weeks after the treatment series, and 8 weeks after the treatment series